Evidence map›Paper›PMID 34529050›Full record

Trial reportEuropean heart journal. Cardiovascular Imaging2022

Association of coronary artery calcium score with qualitatively and quantitatively assessed adverse plaque on coronary CT angiography in the SCOT-HEART trial.

Maia Osborne-Grinter, Jacek Kwiecinski, Mhairi Doris, Priscilla McElhinney, Sebastien Cadet, Philip D Adamson, Alastair J Moss, Shirjel Alam, Amanda Hunter, Anoop S V Shah and 14 more

Abstract readClinical Trial
In one paragraph

Trial report in European heart journal. Cardiovascular Imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Maia Osborne-GrinterBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.ORCID 0000-0003-3229-5133
Jacek KwiecinskiBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.
Mhairi DorisBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.
Priscilla McElhinneyBiomedical Imaging Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.ORCID 0000-0002-7642-6804
Sebastien CadetBiomedical Imaging Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.ORCID 0000-0002-9567-6438
Philip D AdamsonBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.ORCID 0000-0002-6177-956X
Alastair J MossNIHR Leicester Biomedical Research Centre and Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Shirjel AlamBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.ORCID 0000-0002-2099-612X
Amanda HunterBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.
Anoop S V ShahDepartment of non-communicable disease epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Nicholas L MillsBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.ORCID 0000-0003-0533-7991
Tania PawadeBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.
Chengjia WangBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.
Jonathan R Weir-McCallDepartment of Radiology, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5842-842X
Giles RoditiInstitute of Cardiovascular & Medical Sciences, Glasgow University, Glasgow, UK.ORCID 0000-0001-9393-7764
Edwin J R van BeekBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.ORCID 0000-0002-2777-5071
Leslee J ShawWeill Cornell Medical College, New York, NY, USA.
Edward D NicolDepartment of Cardiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Daniel BermanBiomedical Imaging Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
Piotr J SlomkaBiomedical Imaging Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
David E NewbyBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.
Marc R DweckBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.ORCID 0000-0001-9847-5917
Damini DeyBiomedical Imaging Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.ORCID 0000-0003-2236-6970
Michelle C WilliamsBHF Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH164SB, UK.ORCID 0000-0003-3556-2428

Funding

Integrated prediction of cardiovascular events by automated coronary plaque and pericoronary adipose tissue quantification from CT AngiographyR01HL148787 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI DEY, DAMINI · 2020 to 2023
$3.0M
Effect of Intensive Medical Treatment on Quantified Coronary Artery Plaque Components with Serial Coronary CTA in Women with Non-Obstructive CADR01HL151266 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI DEY, DAMINI, TAMARAPPOO, BALAJI K. · 2020 to 2023
$1.6M
British Heart Foundation AA/18/3/34220British Heart Foundation CH/09/002British Heart Foundation CH/09/002/26360British Heart Foundation CH/F/21/90010British Heart Foundation CS/18/4/34074British Heart Foundation FS/14/78/31020British Heart Foundation FS/16/14/32023British Heart Foundation FS/17/79/33226British Heart Foundation FS/ICRF/20/26002British Heart Foundation RE/18/5/34216British Heart Foundation RG/16/10/32375British Heart Foundation RG/20/10/34966Chief Scientist Office CZH/4/1135Chief Scientist Office PCL/17/04Medical Research Council G0701127NHLBI NIH HHS R01 HL148787NHLBI NIH HHS R01 HL151266
6 · The paper itself

Abstract

aimsCoronary artery calcification is a marker of cardiovascular risk, but its association with qualitatively and quantitatively assessed plaque subtypes is unknown. METHODS AND

resultsIn this post-hoc analysis, computed tomography (CT) images and 5-year clinical outcomes were assessed in SCOT-HEART trial participants. Agatston coronary artery calcium score (CACS) was measured on non-contrast CT and was stratified as zero (0 Agatston units, AU), minimal (1-9 AU), low (10-99 AU), moderate (100-399 AU), high (400-999 AU), and very high (≥1000 AU). Adverse plaques were investigated by qualitative (visual categorization of positive remodelling, low-attenuation plaque, spotty calcification, and napkin ring sign) and quantitative (calcified, non-calcified, low-attenuation, and total plaque burden; Autoplaque) assessments. Of 1769 patients, 36% had a zero, 9% minimal, 20% low, 17% moderate, 10% high, and 8% very high CACS. Amongst patients with a zero CACS, 14% had non-obstructive disease, 2% had obstructive disease, 2% had visually assessed adverse plaques, and 13% had low-attenuation plaque burden >4%. Non-calcified and low-attenuation plaque burden increased between patients with zero, minimal, and low CACS (P < 0.001), but there was no statistically significant difference between those with medium, high, and very high CACS. Myocardial infarction occurred in 41 patients, 10% of whom had zero CACS. CACS >1000 AU and low-attenuation plaque burden were the only predictors of myocardial infarction, independent of obstructive disease, and 10-year cardiovascular risk score.

conclusionIn patients with stable chest pain, zero CACS is associated with a good but not perfect prognosis, and CACS cannot rule out obstructive coronary artery disease, non-obstructive plaque, or adverse plaque phenotypes, including low-attenuation plaque.

Indexed as

Coronary Artery DiseaseMyocardial InfarctionPlaque, AtheroscleroticVascular CalcificationCalciumComputed Tomography AngiographyCoronary AngiographyHumansPredictive Value of TestsRisk AssessmentRisk FactorsTomography, X-Ray ComputedCalciumatherosclerotic plaquecomputed tomographycomputed tomography coronary angiographycoronary calcium scorelow-attenuation plaque

Identifiers

PMID34529050
PMCPMC9612790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.